Local peripheral effects of μ-opioid receptor agonists in neuropathic pain in rats

被引:75
|
作者
Obara, I [1 ]
Przewlocki, R [1 ]
Przewlocka, B [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, PL-31343 Krakow, Poland
关键词
nerve ligation injurt; peripheral mu-opioid receptor; opioid; antinociception; DAMGO; endomorphins;
D O I
10.1016/j.neulet.2004.01.056
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Our Study was designed to demonstrate peripheral antinociception of the mu-opioid receptor agonists: morphine (MF), [D-Ala(2), N-Me-Phe(4). Gly(5)-ol]enkephalin (DAMGO). endomorphin-1 (EM-1) and endomorphin-2 (EM-2) in Bennett's rat model of neuropathic pain. All the agonists were effective in antagonizing allodynia after their intraplantar (i.pl.) but not subcutaneous (s.c.) administration. Opioid peptides: DAMGO, EM-1 and EM-2 were more effective compared with corresponding doses of morphine (opioid alkaloid) in alleviating chronic pain. Peripheral mu-opioid receptors mediated the observed effects, as was evidenced by the i.pl. treatment with naloxone methiodide (active only at the site of injection) and by cyprodime, a selective mu-opioid receptor antagonist. These results have shown that opioid peptides are effective also after local treatment. and that their peripheral use may be of therapeutic interest in long-term management of chronic pain. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:85 / 89
页数:5
相关论文
共 50 条
  • [1] Selective δ opioid receptor agonists for inflammatory and neuropathic pain
    Dondio, G
    Ronzoni, S
    Farina, C
    Graziani, D
    Parini, C
    Petrillo, P
    Giardina, GAM
    [J]. FARMACO, 2001, 56 (1-2): : 117 - 119
  • [2] Different actions of opioid and cannabinoid receptor agonists in neuropathic pain
    Kohno, Tatsuro
    [J]. MOLECULAR PAIN, 2006, 2
  • [3] Suppression of neuropathic pain by peripheral electrical stimulation in rats:: μ-opioid receptor and NMDA receptor implicated
    Sun, RQ
    Wang, HC
    Wan, Y
    Jing, Z
    Luo, F
    Han, JS
    Wang, Y
    [J]. EXPERIMENTAL NEUROLOGY, 2004, 187 (01) : 23 - 29
  • [4] Effects of Peripheral μ, δ, and κ-Opioid Receptor Agonists on the Levels of Anxiety and Motor Activity of Rats
    E. V. Alexeeva
    G. A. Nazarova
    S. K. Sudakov
    [J]. Bulletin of Experimental Biology and Medicine, 2012, 153 : 720 - 721
  • [5] Effects of Peripheral μ, δ, and κ-Opioid Receptor Agonists on the Levels of Anxiety and Motor Activity of Rats
    Alexeeva, E. V.
    Nazarova, G. A.
    Sudakov, S. K.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 153 (05) : 720 - 721
  • [6] Differential brain opioid receptor availability in central and peripheral neuropathic pain
    Maarrawi, Joseph
    Peyron, Roland
    Mertens, Patrick
    Costes, Ncolas
    Magnin, Michel
    Sindou, Marc
    Laurent, Bernard
    Garcia-Larrea, Luis
    [J]. PAIN, 2007, 127 (1-2) : 183 - 194
  • [7] Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain
    Obara, Ilona
    Parkitna, Jan Rodriguez
    Korostynski, Michal
    Makuch, Wioletta
    Kaminska, Dorota
    Przewlocka, Barbara
    Przewlocki, Ryszard
    [J]. PAIN, 2009, 141 (03) : 283 - 291
  • [8] Loperamide, a peripheral Mu-Opioid receptor agonist, attenuates chemotherapy-induced neuropathic pain in rats
    Gadepalli, Anagha
    Ummadisetty, Obulapathi
    Akhilesh
    Chouhan, Deepak
    Anmol
    Tiwari, Vinod
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [9] The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain
    Al-Khrasani, Mahmoud
    Lacko, Erzsebet
    Riba, Pal
    Kiraly, Kornel
    Sobor, Melinda
    Timar, Julia
    Mousa, Shaaban
    Schaefer, Michael
    Fuerst, Susanna
    [J]. BRAIN RESEARCH BULLETIN, 2012, 87 (2-3) : 238 - 243
  • [10] κ-Opioid receptor agonists in pain treatment
    Pergolizzi, J. V., Jr.
    LeQuang, J. A.
    Taylor, R., Jr.
    Ossipov, M. H.
    Raffa, R. B.
    [J]. DRUGS OF THE FUTURE, 2019, 44 (01) : 39 - 48